SELECTED FINANCIAL INFORMATION
The following table provides selected financial information of the Company, which was derived from, and should be read in conjunction with, the unaudited consolidated financial statements for the three and nine months ended September 30, 2016.
|
|
Three Months Ended September 30, |
Nine Months Ended September 30, | ||||||
|
|
|
2016 |
|
2015 |
|
2016 |
|
2015 |
|
Revenue |
$ |
20,651 |
$ |
15,019 |
$ |
53,776 |
$ |
23,252 |
|
Other operating income |
|
61 |
|
411 |
|
756 |
|
4,476 |
|
|
|
20,712 |
|
15,430 |
|
54,532 |
|
27,728 |
|
Operating costs |
|
|
|
|
|
|
|
|
|
Direct costs, selling, general and administrative expenses |
|
13,853 |
|
12,618 |
|
42,895 |
|
20,734 |
|
Research expenditures |
|
844 |
|
5,215 |
|
4,073 |
|
10,317 |
|
Depreciation and amortization |
|
6,321 |
|
5,838 |
|
19,277 |
|
6,003 |
|
Asset impairment |
|
7,780 |
|
- |
|
7,780 |
|
- |
|
Share-based payments |
|
769 |
|
946 |
|
1,892 |
|
2,297 |
|
|
|
29,567 |
|
24,617 |
|
75,917 |
|
39,351 |
|
Operating loss |
|
(8,855) |
|
(9,187) |
|
(21,385) |
|
(11,623) |
|
Acquisition costs |
|
- |
|
(2,295) |
|
- |
|
(5,325) |
|
Net finance costs |
|
(535) |
|
(147) |
|
(1,636) |
|
(276) |
|
Loss on derivative financial instruments |
|
(775) |
|
- |
|
(775) |
|
- |
|
Foreign exchange (loss) gain |
|
296 |
|
(235) |
|
(106) |
|
(66) |
|
Loss before income taxes |
|
(9,869) |
|
(11,864) |
|
(23,902) |
|
(17,290) |
|
Income tax recovery (expense) |
|
251 |
|
(83) |
|
2,907 |
|
(83) |
|
Net loss |
|
(9,618) |
|
(11,947) |
|
(20,995) |
|
(17,373) |
|
Other comprehensive income (loss) |
|
1,425 |
|
6,201 |
|
(2,031) |
|
6,199 |
|
Comprehensive loss |
$ |
(8,193) |
$ |
(5,746) |
$ |
(23,026) |
$ |
(11,174) |
|
Net loss per share – basic and diluted |
$ |
(0.09) |
$ |
(0.12) |
$ |
(0.20) |
$ |
(0.22) |
